These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15834064)

  • 1. Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy.
    Wendling D; Auge B; Bettinger D; Lohse A; Le Huede G; Bresson-Hadni S; Toussirot E; Miguet JP; Herbein G; Di Martino V
    Ann Rheum Dis; 2005 May; 64(5):788-9. PubMed ID: 15834064
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab and reactivation of cerebral toxoplasmosis.
    Young JD; McGwire BS
    N Engl J Med; 2005 Oct; 353(14):1530-1; discussion 1530-1. PubMed ID: 16207863
    [No Abstract]   [Full Text] [Related]  

  • 3. Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy.
    Wendling D; Di Martino V; Prati C; Toussirot E; Herbein G
    Joint Bone Spine; 2009 May; 76(3):308-11. PubMed ID: 19346146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection.
    Matsumoto T; Marusawa H; Dogaki M; Suginoshita Y; Inokuma T
    Liver Int; 2010 Sep; 30(8):1241-2. PubMed ID: 20345703
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic viral hepatitis and TNF-alpha blockade.
    Raftery G; Griffiths B; Kay L; Kane D
    Rheumatology (Oxford); 2007 Aug; 46(8):1381; author reply 1381-2. PubMed ID: 17567635
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
    J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept.
    Germanidis G; Hytiroglou P; Zakalka M; Settas L
    J Hepatol; 2012 Jun; 56(6):1420-1. PubMed ID: 22127282
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
    Carroll MB; Bond MI
    Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
    Delaunay C; Farrenq V; Marini-Portugal A; Cohen JD; Chevalier X; Claudepierre P
    J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease.
    Michel M; Duvoux C; Hezode C; Cherqui D
    J Rheumatol; 2003 Jul; 30(7):1624-5. PubMed ID: 12858469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab.
    Anelli MG; Torres DD; Manno C; Scioscia C; Iannone F; Covelli M; Schena FP; Lapadula G
    Arthritis Rheum; 2005 Aug; 52(8):2519-20. PubMed ID: 16052569
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG; Colmenero JD; Irigoyen MV
    J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis.
    Torre-Cisneros J; Del Castillo M; Castón JJ; Castro MC; Pérez V; Collantes E
    Rheumatology (Oxford); 2005 Sep; 44(9):1132-5. PubMed ID: 15927999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.
    Ojiro K; Naganuma M; Ebinuma H; Kunimoto H; Tada S; Ogata H; Iwao Y; Saito H; Hibi T
    J Gastroenterol; 2008; 43(5):397-401. PubMed ID: 18592158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Mitroulis I; Hatzara C; Kandili A; Hadziyannis E; Vassilopoulos D
    Ann Rheum Dis; 2013 Feb; 72(2):308-10. PubMed ID: 22930597
    [No Abstract]   [Full Text] [Related]  

  • 18. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
    Perceau G; Diris N; Estines O; Derancourt C; Lévy S; Bernard P
    Br J Dermatol; 2006 Nov; 155(5):1053-6. PubMed ID: 17034541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.
    Fanouriakis A; Vassilopoulos D; Repa A; Boumpas DT; Sidiropoulos P
    Rheumatology (Oxford); 2014 Jan; 53(1):195-6. PubMed ID: 23771951
    [No Abstract]   [Full Text] [Related]  

  • 20. Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.
    Niscola P; Del Principe MI; Maurillo L; Venditti A; Buccisano F; Piccioni D; Amadori S; Del Poeta G
    Leukemia; 2005 Oct; 19(10):1840-1. PubMed ID: 16094417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.